Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the ...
The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level ...
"If CMS reduces it below 90%, I will be the first to push to eliminate, as that was not the deal we made," said Rep. Donny ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback